Programme

WORKSHOPS: June 3rd (Wednesday)

09:00	Registration (Continues all day)
10:00 – 12:00	Funding prospects in the current climate Steve Jacobson & Fatah Kashanchi
12:00 – 13:00	Lunch
12:00 – 15:00	Workshop 1 Public Health, Transmission, and Community Engagement Ensuring blood safety, and interrupting HTLV transmission Sheila O ’Brien HTLV-1 Pre-Exposure Prophylaxis Working Group Fabiola Martin Public heath impact of HTLV in vulnerable populations and geographic areas in Peru Eduardo Gotuzzo HTLV transmission in Europe Andrea Thoma-Kress Status of HTLV-1 in Aboriginals communities Lloyd Einsiedel HTLV challenges and opportunities in the international public health agenda Peter Figueroa	Workshop 2 Molecular Virology and Immunopathogenesis Molecular Virology of HTLV Benoit Barbeau, Canada Mechanisms of latent HTLV-1 infection, clonal evolution and genetic landscape of ATLL Yorifumi Satou HTLV-1-induced immune dysfunction Helene Dutartre HTLV-1 particle assembly and transmission Louis Mansky HTLV-1 immunopathogenesis Sharron Manuel Genetic landscape and clonal evolution of ATLL Aileen Rowan
15:00 – 15:30	Coffee break
15:30 – 17:30	Workshop 3 HTLV epidemiology, phylogenetics, and diagnostics Standardizing molecular diagnosis of HTLV infections Philippa Hetzel Genetic diversity of HTLV-1 and its molecular epidemiology Philippe Afonso Diagnosis of HTLV infections in early life Carolina Rosadas Prognostic – CNS Biomarkers of HTLV-associated neuroinflammation Yoshi Yamano Molecular epidemiology of HTLVs in the Americas Antonio Vallinoto IRVA Africa meeting, safety of blood transfusions in Africa and the need to inform public policy Jean-Claude Twizere	Workshop 4 Preclinical models, clinical guidelines, and trials HTLV animal models (ATLL & HAM/TSP) Patrick Green US National Cancer Research Network (NCCN) guidelines Steven Horwitz Targeting Epigenetic and Other Pathways in ATLL Toshiki Watanabe Evidence-based treatment recommendations for ATLL Lucy Cook Advances in Stem Cell Transplant for ATLL Ali Bazarbachi Current & emerging therapeutic strategies for ATLL in USA Georgios Pongas
17:30 -19:00	Welcome Reception